BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26034654)

  • 1. Metabolic liver function measured in vivo by dynamic (18)F-FDGal PET/CT without arterial blood sampling.
    Horsager J; Munk OL; Sørensen M
    EJNMMI Res; 2015; 5():32. PubMed ID: 26034654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lumped constant for the galactose analog 2-18F-fluoro-2-deoxy-D-galactose is increased in patients with parenchymal liver disease.
    Mikkelsen KS; Sørensen M; Frisch K; Villadsen GE; Bibby BM; Keiding S
    J Nucl Med; 2014 Apr; 55(4):590-4. PubMed ID: 24591487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic liver function in humans measured by 2-
    Bak-Fredslund KP; Lykke Eriksen P; Munk OL; Villadsen GE; Keiding S; Sørensen M
    EJNMMI Res; 2017 Aug; 7(1):71. PubMed ID: 28853060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography of liver tumours without blood sampling.
    Keiding S; Munk OL; Schiøtt KM; Hansen SB
    Eur J Nucl Med; 2000 Apr; 27(4):407-12. PubMed ID: 10805113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.
    Sørensen M; Mikkelsen KS; Frisch K; Villadsen GE; Keiding S
    J Hepatol; 2013 Jun; 58(6):1119-24. PubMed ID: 23339954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of hepatic galactose elimination capacity using 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT: reproducibility of the method and metabolic heterogeneity in a normal pig liver model.
    Sørensen M
    Scand J Gastroenterol; 2011 Jan; 46(1):98-103. PubMed ID: 20695723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.
    Sørensen M; Mikkelsen KS; Frisch K; Bass L; Bibby BM; Keiding S
    J Nucl Med; 2011 Oct; 52(10):1566-72. PubMed ID: 21875925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT of hepatocellular carcinoma is not improved by co-administration of galactose.
    Bak-Fredslund KP; Munk OL; Keiding S; Sørensen M
    Nucl Med Biol; 2016 Sep; 43(9):577-580. PubMed ID: 27434609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic blood perfusion measured by 3-minute dynamic 18F-FDG PET in pigs.
    Winterdahl M; Munk OL; Sørensen M; Mortensen FV; Keiding S
    J Nucl Med; 2011 Jul; 52(7):1119-24. PubMed ID: 21680685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic uptake and metabolism of galactose can be quantified in vivo by 2-[18F]fluoro-2-deoxygalactose positron emission tomography.
    Sørensen M; Munk OL; Mortensen FV; Olsen AK; Bender D; Bass L; Keiding S
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G27-G36. PubMed ID: 18483186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal 2-[(18)F]fluoro-2-deoxy-D-galactose PET/CT protocol for detection of hepatocellular carcinoma.
    Horsager J; Bak-Fredslund K; Larsen LP; Villadsen GE; Bogsrud TV; Sørensen M
    EJNMMI Res; 2016 Dec; 6(1):56. PubMed ID: 27341819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tracer input for kinetic modelling of liver physiology determined without sampling portal venous blood in pigs.
    Winterdahl M; Keiding S; Sørensen M; Mortensen FV; Alstrup AK; Munk OL
    Eur J Nucl Med Mol Imaging; 2011 Feb; 38(2):263-70. PubMed ID: 20882283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-
    Isohashi K; Shimosegawa E; Naka S; Kanai Y; Horitsugi G; Mochida I; Matsunaga K; Watabe T; Kato H; Tatsumi M; Hatazawa J
    EJNMMI Res; 2016 Dec; 6(1):75. PubMed ID: 27757932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [
    Sørensen M; Fode MM; Petersen JB; Holt MI; Høyer M
    Radiat Oncol; 2021 Oct; 16(1):192. PubMed ID: 34598730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplified [18F]FDG image-derived input function using the left ventricle, liver, and one venous blood sample.
    Tantawy MN; Peterson TE
    Mol Imaging; 2010 Apr; 9(2):76-86. PubMed ID: 20236605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling.
    Munk OL; Bass L; Roelsgaard K; Bender D; Hansen SB; Keiding S
    J Nucl Med; 2001 May; 42(5):795-801. PubMed ID: 11337579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative PET of liver functions.
    Keiding S; Sørensen M; Frisch K; Gormsen LC; Munk OL
    Am J Nucl Med Mol Imaging; 2018; 8(2):73-85. PubMed ID: 29755841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of image-derived input function using a long axial field of view PET/CT scanner for two different tracers.
    Palard-Novello X; Visser D; Tolboom N; Smith CLC; Zwezerijnen G; van de Giessen E; den Hollander ME; Barkhof F; Windhorst AD; van Berckel BN; Boellaard R; Yaqub M
    EJNMMI Phys; 2024 Mar; 11(1):25. PubMed ID: 38472680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An input function estimation method for FDG-PET human brain studies.
    Guo H; Renaut RA; Chen K
    Nucl Med Biol; 2007 Jul; 34(5):483-92. PubMed ID: 17591548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cardiac image-derived input functions for quantitative whole body [
    Reed MB; Godbersen GM; Vraka C; Rausch I; Ponce de León M; Popper V; Geist B; Nics L; Komorowski A; Karanikas G; Beyer T; Traub-Weidinger T; Hahn A; Langsteger W; Hacker M; Lanzenberger R
    Front Physiol; 2023; 14():1074052. PubMed ID: 37035658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.